These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30638876)

  • 1. Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity.
    Varano F; Catarzi D; Falsini M; Dal Ben D; Buccioni M; Marucci G; Volpini R; Colotta V
    Bioorg Med Chem Lett; 2019 Feb; 29(4):563-569. PubMed ID: 30638876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A
    Varano F; Catarzi D; Falsini M; Vincenzi F; Pasquini S; Varani K; Colotta V
    Bioorg Med Chem; 2018 Jul; 26(12):3688-3695. PubMed ID: 29880250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the 7-oxo-thiazolo[5,4-d]pyrimidine core for the design of new human adenosine A3 receptor antagonists. Synthesis, molecular modeling studies and pharmacological evaluation.
    Varano F; Catarzi D; Squarcialupi L; Betti M; Vincenzi F; Ravani A; Varani K; Dal Ben D; Thomas A; Volpini R; Colotta V
    Eur J Med Chem; 2015; 96():105-21. PubMed ID: 25874336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors.
    Squarcialupi L; Falsini M; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Dal Ben D; Lambertucci C; Volpini R; Colotta V
    Bioorg Med Chem; 2016 Jun; 24(12):2794-808. PubMed ID: 27161878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives.
    Federico S; Redenti S; Sturlese M; Ciancetta A; Kachler S; Klotz KN; Cacciari B; Moro S; Spalluto G
    PLoS One; 2015; 10(12):e0143504. PubMed ID: 26625265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [1,2,4]Triazolo[1,5-c]pyrimidines as adenosine receptor antagonists: Modifications at the 8 position to reach selectivity towards A
    Federico S; Margiotta E; Salmaso V; Pastorin G; Kachler S; Klotz KN; Moro S; Spalluto G
    Eur J Med Chem; 2018 Sep; 157():837-851. PubMed ID: 30144700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship studies and pharmacological characterization of N
    Varano F; Catarzi D; Vincenzi F; Falsini M; Pasquini S; Borea PA; Colotta V; Varani K
    Eur J Med Chem; 2018 Jul; 155():552-561. PubMed ID: 29909340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted 4-phenylthiazoles: Development of potent and selective A
    Abdelrahman A; Yerande SG; Namasivayam V; Klapschinski TA; Alnouri MW; El-Tayeb A; Müller CE
    Eur J Med Chem; 2020 Jan; 186():111879. PubMed ID: 31780082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility.
    Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Monopoli A; Ongini E; Varani K; Borea PA
    J Med Chem; 2002 Jan; 45(1):115-26. PubMed ID: 11754583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A
    Falsini M; Squarcialupi L; Catarzi D; Varano F; Betti M; Dal Ben D; Marucci G; Buccioni M; Volpini R; De Vita T; Cavalli A; Colotta V
    J Med Chem; 2017 Jul; 60(13):5772-5790. PubMed ID: 28590753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of simplified N²-substituted pyrazolo[3,4-d]pyrimidine derivatives as novel adenosine receptor antagonists: efficient synthetic approaches, biological evaluations and molecular docking studies.
    Venkatesan G; Paira P; Cheong SL; Vamsikrishna K; Federico S; Klotz KN; Spalluto G; Pastorin G
    Bioorg Med Chem; 2014 Mar; 22(5):1751-65. PubMed ID: 24518296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists.
    Redenti S; Ciancetta A; Pastorin G; Cacciari B; Moro S; Spalluto G; Federico S
    Curr Top Med Chem; 2016; 16(28):3224-3257. PubMed ID: 27150365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists.
    Vazquez-Rodriguez S; Matos MJ; Santana L; Uriarte E; Borges F; Kachler S; Klotz KN
    J Pharm Pharmacol; 2013 May; 65(5):697-703. PubMed ID: 23600387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel 7-imino-2-thioxo-3,7-dihydro-2H-thiazolo [4,5-d] pyrimidine derivatives as adenosine A2A receptor antagonists.
    Luthra PM; Mishra CB; Jha PK; Barodia SK
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1214-8. PubMed ID: 20018509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
    Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
    J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: structural investigations at the 5-position to target human A₁ and A(2A) adenosine receptors. Molecular modeling and pharmacological studies.
    Squarcialupi L; Colotta V; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Borea PA; Porta N; Ciancetta A; Moro S
    Eur J Med Chem; 2014 Sep; 84():614-27. PubMed ID: 25063944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A
    Falsini M; Catarzi D; Varano F; Dal Ben D; Marucci G; Buccioni M; Volpini R; Di Cesare Mannelli L; Ghelardini C; Colotta V
    Bioorg Chem; 2019 Jun; 87():380-394. PubMed ID: 30913470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Aryladenine Derivatives as a Potent Scaffold for Adenosine Receptor Antagonists: The 6-Morpholino Derivatives.
    Areias F; Correia C; Rocha A; Teixeira S; Castro M; Brea J; Hu H; Carlsson J; Loza MI; Proença MF; Carvalho MA
    Molecules; 2024 May; 29(11):. PubMed ID: 38893418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New substituted 9-alkylpurines as adenosine receptor ligands.
    Camaioni E; Costanzi S; Vittori S; Volpini R; Klotz KN; Cristalli G
    Bioorg Med Chem; 1998 May; 6(5):523-33. PubMed ID: 9629466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists.
    Baraldi PG; Baraldi S; Saponaro G; Aghazadeh Tabrizi M; Romagnoli R; Ruggiero E; Vincenzi F; Borea PA; Varani K
    J Med Chem; 2015 Jul; 58(13):5355-60. PubMed ID: 26046697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.